Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 2/20 | 0.67 |
| ▸ | PRKCG | P05129 | 2/20 | 0.67 |
| ▸ | PRKCB | P05771 | 2/20 | 0.67 |
| ▸ | PRKCA | P17252 | 2/20 | 0.67 |
| ▸ | PRKCH | P24723 | 2/20 | 0.67 |
| ▸ | PRKCI | P41743 | 2/20 | 0.67 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.67 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.67 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.67 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.67 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.67 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | AKT1 | P31749 | 2/20 | 0.53 |
| ▸ | ESR1 | P03372 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | CDC25A | P30304 | 1/20 | 0.53 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL290985 | 1.00 | PRKD3 (0.67) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL28598698 | 1.00 | PRKD3 (0.67) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL5440696 | 1.00 | PRKD3 (0.67) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL8855849 | 1.00 | PRKD3 (0.67) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL8855744 | 1.00 | PRKD3 (0.67) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL8855768 | 1.00 | PRKD3 (0.67) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL8855786 | 1.00 | PRKD3 (0.67) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL8855806 | 1.00 | PRKD3 (0.67) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL14560967 | 1.00 | PRKD3 (0.67) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Hydrochloric Acid SCHEMBL25306967 | 0.98 | PRKD3 (0.65) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260001791-A1 | METHOD AND SYSTEM OF REMOVING ENVIRONMENTAL CONTAMINANTS FROM WATER | WEGNER PAUL CHARLES (US) | 2026-01-01 | — | — | US | claimed |
| WO-2023287675-A1 | METHOD AND SYSTEM OF REMOVING ENVIRONMENTAL CONTAMINANTS FROM WATER | WEGNER PAUL CHARLES (US) | 2023-01-19 | — | — | WO | claimed |
| US-20230009795-A1 | METHOD AND SYSTEM OF REMOVING ENVIRONMENTAL CONTAMINANTS FROM WATER | WEGNER PAUL CHARLES (US) | 2023-01-12 | — | — | US | claimed |
| CN-101374805-A | Organic derivatives, their salts and use for the control of phytopathogens | ISAGRO SPA (IT) | 2009-02-25 | — | — | CN | claimed |
| WO-2005018631-A1 | USE OF CHOLINE DERIVATIVES FOR MEMORY, LEARNING AND COGNITION | PATEL HASMUKH (US) | 2005-03-03 | — | — | WO | claimed |
| US-20050038116-A1 | Novel class of compounds (Choline derivatives, esp. Stearyl Choline Cloride and other salts) for the treatment of Alzheimer's disease, Down syndrome and central (and/or peripheral) nervous system and memory related disorders or for enhancements | PATEL HASMUKH B (US) | 2005-02-17 | — | — | US | claimed |
| US-20260001791-A1 | METHOD AND SYSTEM OF REMOVING ENVIRONMENTAL CONTAMINANTS FROM WATER | WEGNER PAUL CHARLES (US) | 2026-01-01 | — | — | US | disclosed |
| US-12428325-B2 | Method and system of removing environmental contaminants from water | WEGNER PAUL CHARLES (US) | 2025-09-30 | — | — | US | disclosed |
| WO-2023287675-A1 | METHOD AND SYSTEM OF REMOVING ENVIRONMENTAL CONTAMINANTS FROM WATER | WEGNER PAUL CHARLES (US) | 2023-01-19 | — | — | WO | disclosed |
| US-20230009795-A1 | METHOD AND SYSTEM OF REMOVING ENVIRONMENTAL CONTAMINANTS FROM WATER | WEGNER PAUL CHARLES (US) | 2023-01-12 | — | — | US | disclosed |
| CN-101374805-B | Organic derivatives, their salts and use for the control of phytopathogens | ISAGRO SPA | 2013-10-16 | — | — | CN | disclosed |
| CN-101374805-A | Organic derivatives, their salts and use for the control of phytopathogens | ISAGRO SPA (IT) | 2009-02-25 | — | — | CN | disclosed |
| CN-101068823-A | Tetrahydropyrane derivatives for use as antidiabetics | MERCK PATENT GMBH (DE) | 2007-11-07 | — | — | CN | disclosed |
| US-20070154546-A1 | Sustained release pharmaceutical compositions | INTERNATIONAL MEDICATION SYSTEMS, LIMITED | 2007-07-05 | — | — | US | disclosed |
| US-20050038116-A1 | Novel class of compounds (Choline derivatives, esp. Stearyl Choline Cloride and other salts) for the treatment of Alzheimer's disease, Down syndrome and central (and/or peripheral) nervous system and memory related disorders or for enhancements | PATEL HASMUKH B (US) | 2005-02-17 | — | — | US | disclosed |
| US-20050038116-A1 | Novel class of compounds (Choline derivatives, esp. Stearyl Choline Cloride and other salts) for the treatment of Alzheimer's disease, Down syndrome and central (and/or peripheral) nervous system and memory related disorders or for enhancements | PATEL HASMUKH B (US) | 2005-02-17 | — | — | US | disclosed |
| US-20050038116-A1 | Novel class of compounds (Choline derivatives, esp. Stearyl Choline Cloride and other salts) for the treatment of Alzheimer's disease, Down syndrome and central (and/or peripheral) nervous system and memory related disorders or for enhancements | PATEL HASMUKH B (US) | 2005-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070154546-A1 | Sustained release pharmaceutical compositions | PLA2G2C, PLTP, F12 | PRKD3 3946/4885PRKCG 2762/4885PRKCB 3837/4885 |
| US-20050038116-A1 | Novel class of compounds (Choline derivatives, esp. Stearyl Choline Cloride and other salts) for the treatment of Alzheimer's disease, Down syndrome and central (and/or peripheral) nervous system and memory related disorders or for enhancements | CHAT, SGMS1, SPTLC3 | PRKD3 590/4885PRKCG 1195/4885PRKCB 936/4885 |
| US-20260001791-A1 | METHOD AND SYSTEM OF REMOVING ENVIRONMENTAL CONTAMINANTS FROM WATER | SGMS2, SGMS1, PFAS | PRKD3 2346/4885PRKCG 2695/4885PRKCB 2240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.